Subheim Approach 2008 Rare
I just had to post and say - wow. This is an amazing album.
Upload: 8-10-2014, 12:17 200 Performer: Subheim Album: Approach Label: Tympanik Audio Style: Downtempo,Electronic, Ambient Year: 2008 Format: FLAC (tracks +.cue. Find a Subheim - Approach first pressing. What Subheim's Approach has over most of those recordings is that it's very. In the first months of 2008.
The Definition Of Approached
It's been my experience that a lot of albums with very high ratings on discogs labeled (among other things) as IDM tend to be disappointing, often repetitive, technically unchallenging, Basic Channel-derivative and forgettable. I further qualify this review by saying I'm not a big fan of all of what's found on the Tympanik label. What Subheim's Approach has over most of those recordings is that it's very smooth and not at all glitchy. 'Voces Perdidas' is one of the most darkly, sensuously beautiful female vocal-lead tracks of this type since 'Rachel's Song' off the Vangelis Blade Runner soundtrack. That's the best way I can describe this album - dark, sensual beauty. 'Howl,' the two versions of 'Hollow,' and the last track are my favorites.
Highly recommended, I think this is a can't-miss. I first came across Tympanik Audio, a Chicago based label with the dark electronic roster, late in 2007, with their first double compilation release, Emerging Organisms. In the first months of 2008, I reviewed an intelligent rhythmic industrial album by Totakeke, ELekatota. But with this fourth catalog release, I can shamelessly proclaim that Tympanik has struck gold. With the release of Approach, Tympanik is quickly gaining momentum to the ranks of the beloved Hymen and Ad Noiseam.
Subheim is the brainchild of Greek composer, Kostas K, whose complete biography is shadowed by the haunting sounds and occasional sighing voices of Katja. The organic elements of piano, cello, and ambient atmospheres are struck with slow building crispy beats and bitcrushed digital sounds. Approach is Subheims debut album. It perfectly encompasses all of my favorite elements: orchestral, cinematic, dark, crunchy, rhythmic, and extremely musical. 'Moved by subjects such as urban isolation and the outburst of mankind's deepest emotions, Subheim delivers the ideal soundtrack for those moments of chaos or melancholy reflections.' After half a dozen listens and consecutive ratings of five stars on my playlist, I give up and throw my hands in the air.
I refuse to rate music with numbers, so hopefully these words will speak for themselves, as I attempt to contain my excitement for Subheim. Being filed right along my top favorite artists in the genre, Architect, Kattoo, Hecq, Lusine Icl, Arovane, Gridlock and Aaron Spectre. Highly recommended! Do not miss this next step in evolution of electronic music.
Abstract Purpose To estimate scleroderma prevalence in Spain. Methods As no data were available for Spain we used reported scleroderma incidence (Silman's study on UK and Alamanos' on Greece), scleroderma cause-specific mortality, obtained through the National Institute of Statistics (codes included in M34 of the International Classification of Diseases, 10th revision) in Spain and remission data. Estimates were applied to the Spanish population and to all-cause mortality for 2004, broken down by age group and gender. Estimators were assumed to follow a Poisson distribution.
DisMod-II software was used for this purpose. Results Estimated prevalence was 0.23 and 0.71 cases per 10 000 people for men and women, respectively, based on UK incidence, and 0.28 and 2.58 cases per 10 000 people, respectively, based on Greek incidence. Estimated age at disease onset ranged from 50 to 58 years among men and from 52 to 55 among women, according to UK and Greek data, respectively. Mean duration of the disease was estimated to be in the range of 17–20 years for men and 19–20 for women.
Another Word For Approach
Conclusions DisMod-II is useful for obtaining, modelling and confirming variability ranges of prevalence found in literature. It also provides information for orphan drug designation and for supporting public health decisions regarding rare diseases. Copyright © 2008 John Wiley & Sons, Ltd.